141 related articles for article (PubMed ID: 34087785)
21. Patterns and Drivers of Costs for Neuroendocrine Tumor Care: A Comparative Population-Based Analysis.
Hallet J; Law CHL; Cheung M; Mittmann N; Liu N; Fischer HD; Singh S
Ann Surg Oncol; 2017 Oct; 24(11):3312-3323. PubMed ID: 28695392
[TBL] [Abstract][Full Text] [Related]
22. Noncancer deaths in white adult cancer patients.
Brown BW; Brauner C; Minnotte MC
J Natl Cancer Inst; 1993 Jun; 85(12):979-87. PubMed ID: 8496983
[TBL] [Abstract][Full Text] [Related]
23. Incidence of psychiatric illness in patients with neuroendocrine tumors: a comparative population-based analysis.
Hallet J; Isenberg-Grzeda E; Law CHL; Barabash V; Zuckerman J; Singh S; Myrehaug SD; Assal A; Chan WC; Coburn NG; Mahar AL
Support Care Cancer; 2022 Nov; 30(11):9635-9646. PubMed ID: 36197513
[TBL] [Abstract][Full Text] [Related]
24. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
25. Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
Kipnis ST; Hung M; Kumar S; Heckert JM; Lee H; Bennett B; Soulen MC; Pryma DA; Mankoff DA; Metz DC; Eads JR; Katona BW
JAMA Netw Open; 2021 Mar; 4(3):e212274. PubMed ID: 33755166
[TBL] [Abstract][Full Text] [Related]
26. Neuroendocrine tumors and second primary malignancy--a relationship with clinical impact?
Prommegger R; Ensinger C; Steiner P; Sauper T; Profanter C; Margreiter R
Anticancer Res; 2004; 24(2C):1049-51. PubMed ID: 15154621
[TBL] [Abstract][Full Text] [Related]
27. Elderly Patients with Metastatic Neuroendocrine Tumors Are Undertreated and Have Shorter Survival: The LyREMeNET Study.
Lemelin A; Maucort-Boulch D; Castel-Kremer E; Forestier J; Hervieu V; Lorcet M; Boutitie F; Theillaumas A; Robinson P; Duclos A; Lombard-Bohas C; Walter T
Neuroendocrinology; 2020; 110(7-8):653-661. PubMed ID: 31586998
[TBL] [Abstract][Full Text] [Related]
28. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
29. 177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours: response to treatment and long-term survival update.
Demirci E; Kabasakal L; Toklu T; Ocak M; Şahin OE; Alan-Selcuk N; Araman A
Nucl Med Commun; 2018 Aug; 39(8):789-796. PubMed ID: 29912750
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
[TBL] [Abstract][Full Text] [Related]
31. Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors.
Dromain C; Pavel ME; Ruszniewski P; Langley A; Massien C; Baudin E; Caplin ME;
BMC Cancer; 2019 Jan; 19(1):66. PubMed ID: 30642293
[TBL] [Abstract][Full Text] [Related]
32. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
[TBL] [Abstract][Full Text] [Related]
33. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
[TBL] [Abstract][Full Text] [Related]
34. Second primary malignancies in patients with neuroendocrine tumors.
Reina JJ; Serrano R; Codes M; Jiménez E; Bolaños M; Gonzalez E; Sevilla I
Clin Transl Oncol; 2014 Oct; 16(10):921-6. PubMed ID: 24788817
[TBL] [Abstract][Full Text] [Related]
35. Risk of Primary Neuroendocrine Pancreatic Tumor After a First Primary Cancer: A US Population-Based Study.
Kamath GR; Kim MK; Taioli E
Pancreas; 2019 Feb; 48(2):161-168. PubMed ID: 30589832
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological characteristics and frequency of multiple rectal neuroendocrine tumors: a single-center retrospective study.
Nishikawa Y; Chino A; Ide D; Saito S; Igarashi M; Takamatsu M; Fujisaki J; Igarashi Y
Int J Colorectal Dis; 2019 Nov; 34(11):1887-1894. PubMed ID: 31630212
[TBL] [Abstract][Full Text] [Related]
37. A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.
Abdel-Qadir H; Austin PC; Lee DS; Amir E; Tu JV; Thavendiranathan P; Fung K; Anderson GM
JAMA Cardiol; 2017 Jan; 2(1):88-93. PubMed ID: 27732702
[TBL] [Abstract][Full Text] [Related]
38. A population-based study of outcomes in patients with gastrointestinal neuroendocrine tumours.
McMullen T; Al-Jahdali A; de Gara C; Ghosh S; McEwan A; Schiller D
Can J Surg; 2017 Jun; 60(3):192-197. PubMed ID: 28327275
[TBL] [Abstract][Full Text] [Related]
39. An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan.
Chang JS; Chen LT; Shan YS; Chu PY; Tsai CR; Tsai HJ
Sci Rep; 2021 Apr; 11(1):7881. PubMed ID: 33846396
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]